BioCentury
ARTICLE | Company News

Genzyme, Medtronic cell therapy deal

June 1, 2004 7:00 AM UTC

GENZ and MDT formed a joint venture called MG Biotherapeutics that will combine cell therapy and medical devices to develop treatments for cardiovascular diseases. The companies will co-fund GENZ's on...